BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2787452)

  • 1. Circulating buttock cells in non-Hodgkin's lymphoma.
    Verbunt RJ; den Ottolander GJ; Kluin PM; Brederoo P; Kluin-Nelemans HC
    Leukemia; 1989 Aug; 3(8):578-84. PubMed ID: 2787452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
    Weisenburger DD
    Leukemia; 1991; 5 Suppl 1():26-9. PubMed ID: 1716336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
    Huber H; Gattringer C; Thaler J; Peschel C
    Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histopathology of leukaemic non-Hodgkin's lymphoma in bone marrow].
    Buhr T; Länger F; Schlué J; V Wasielewski R; Kreipe H
    Pathologe; 2002 Nov; 23(6):438-47. PubMed ID: 12436297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
    Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
    Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
    Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
    Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin's lymphomas: an immunohistochemical and histological study.
    Curran RC; Jones EL
    J Pathol; 1979 Dec; 129(4):179-90. PubMed ID: 317105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
    Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
    Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terminal deoxynucleotidyl transferase in diagnosis of lymphomas.
    Rudzka E; Hołowiecki J; Bartnikowa W; Krawczyk M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):245-50. PubMed ID: 2475404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical significance of the immunological phenotype in non-Hodgkin's lymphomas].
    Golenkov AK; Miterev GIu; Popov VM; Shakher AL
    Ter Arkh; 1995; 67(7):30-2. PubMed ID: 7482301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesion molecule expression in CD5-negative/CD10-negative chronic B-cell leukemias: comparison with non-Hodgkin's lymphomas and CD5-positive B-cell chronic lymphocytic leukemia.
    Finn WG; Singleton TP; Schnitzer B; Ross CW; Stoolman LM
    Hum Pathol; 2001 Jan; 32(1):66-73. PubMed ID: 11172297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.
    Jaffe ES; Zarate-Osorno A; Medeiros LJ
    Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-Hodgkin's lymphomas of low-grade malignancy with particular reference to the lymphocytic lymphomas of B-cell origin (author's transl)].
    Wessel H
    Arch Geschwulstforsch; 1979; 49(8):635-47. PubMed ID: 317425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers.
    Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F
    Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin V gene utilization in chronic lymphocytic leukemia and non-Hodgkin's B cell lymphomas.
    Kipps TJ
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):293-8. PubMed ID: 3065730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
    Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
    Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.